Could a balloon replace stents in young heart attack patients?
NCT ID NCT07229248
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a drug-coated balloon to a standard drug-eluting stent in 496 young adults (ages 18–50) having a heart attack. The balloon delivers medication to open the artery without leaving a permanent implant, which may reduce long-term risks like blood clots and the need for extended blood thinner use. Participants will be followed for one year to see if the balloon is as safe and effective as the stent.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
paclitaxel-coated balloon (Prevail DCB)
What this could lead to
If successful, this could offer young heart attack patients a stent-free option that lowers the risk of future heart problems and reduces the need for long-term blood thinners.
What could go wrong
This is a single-center trial, so results may not apply everywhere. The balloon might not keep the artery open as well as a stent, and there is a small risk of the artery closing suddenly during the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEMI (ST ELEVATION MI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institute of Cardiovascular Diseases
RECRUITINGKarachi, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••